Then, we examined the effects of blocking of the microglial Cav1.2 channel on the microglial activation profiles in vitro and the effects of microglia-specific knockdown of Cav1.2 on the symptoms of a PD model in vivo. Here, CACNA1C is linked to Parkinson disease.